// App-Quantinova.ai

1829 : Olaparib antiproliferative effect in pancreatic cancer and correlation with the response to other anticancer agents

Researchers

Presenter

  • Elisabetta Leo

Principal Investigators

  • Giuditta Illuzzi

  • Sabrina Bentouati

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Metastatic pancreatic adenocarcinoma

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Irinotecan

  • Paclitaxel

  • FOLFIRINOX

  • Veliparib

  • Olaparib

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved